EY Pulse of the Industry Medical Technology Report 2023
Every year, the medtech industry looks to the EY Pulse of the Industry Report to shed light on the recent developments and trends impacting our work and patient care. The 17th edition of this report breaks down the enormous promises of AI in supply chain optimization, workforce transformation, remote care and so many other vital areas –while providing a closer look at the data around medtech’s financing picture and financial performance in 2022 and early 2023.
Related Reading
News / Supply Chain
AdvaMed Applauds Biden Administration Efforts to Strengthen Supply Chains, Protect Patients
November 28, 2023
Today, AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the recent actions to strengthen supply chains announced by President Biden as part of the inaugural convening of the White House Council on Supply Chain Resilience:
News / Global & Trade
AdvaMed leads Global Effort to Push Back on Lithium Battery Transport Restrictions
November 13, 2023
As the International Civil Aviation Organization (ICAO) Dangerous Goods Panel meets this week, AdvaMed, the Medtech Association, led a group of 24 global medtech organizations in expressing concerns about the panel’s proposed regulations on the transport of dangerous goods aboard aircraft.
Blog / Global & Trade
AdvaMed Resources for Ukraine Humanitarian Needs
October 24, 2023
AdvaMed is collaborating with the U.S. and Ukrainian governments to facilitate donations of urgently needed medical supplies to Ukraine.
News / COVID-19 / Global & Trade
AdvaMed Statement on USITC report, “COVID-19 Diagnostics and Therapeutics, Supply, Demand, and TRIPS Agreement Flexibilities”
October 20, 2023
The United States International Trade Commission (USITC) released its highly anticipated report,“COVID-19 Diagnostics and Therapeutics, Supply, Demand, and TRIPS Agreement Flexibilities” on October 17. Evidence presented in the 496-page report supports AdvaMed’s position that there is no justification for the World Trade Organization (WTO) to waive intellectual property protection for products used to treat or diagnose COVID-19.
News / Global & Trade
AdvaMed Statement on Israel-Hamas Conflict
October 16, 2023
Today, AdvaMed, the Medtech Association, released the following statement by President and CEO Scott Whitaker:
“On Monday last week, I addressed the MedTech Conference and expressed our profound sadness and concern regarding the Hamas attacks in Israel. And today, I want to reiterate that message.
Blog / Global & Trade
AdvaMed Resources for Crisis in Israel and Gaza
October 16, 2023
In light of the ongoing violence in Gaza and Israel following the attack by Hamas, AdvaMed has launched this page to keep members informed of opportunities to support impacted communities and deliver medical supplies and equipment where needed. We will continue to update this page as more information and resources become available. For any questions, please reach out to Abby Pratt ([email protected]).
Event / China / Global & Trade / Small Business
China Medical Device Webinar with AdvaMed Accel for U.S. Exporters
October 18, 2023
11:00 AM
Join us for a breakdown of the Chinese medical device market, to review the current regulatory requirements and pathways, and address I.P. protection in China for U.S. companies.
News / Global & Trade
AdvaMed’s Whitaker’s Statement on Sec. Raimondo’s Trip to China
August 29, 2023
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on Secretary of Commerce Gina Raimondo’s trip to China.